Stephen E. Gitelman

Also affiliated with University of Exeter, University of San Francisco

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial”.

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Diabetes & Endocrinology(2021)10.1016/s2213-8587(21)00139-x

N/A

4.6DataRank · unranked

135 citations

Brian N. Bundy, Ele Ferrannini, Noha Lim, Lori Blanchfield, Linda A. DiMeglio +60 more

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

JCI Insight(2021)10.1172/jci.insight.147474

N/A

3.4DataRank · unranked

223 citations

Kamir J. Hiam-Galvez, Cody T. Mowery, Kevan C. Herold, Stephen E. Gitelman, Jonathan H. Esensten +15 more

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

JCI Insight(2021)10.1172/jci.insight.150074

N/A

2.2DataRank · unranked

59 citations

Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord +31 more

Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report

Diabetes(2021)10.2337/db20-1103

N/A

0.824DataRank · unranked

24 citations

Jasmine A. Mack, Brittany Bruggeman, Laura M. Jacobsen, Amanda L. Posgai, Clive Wasserfall +9 more

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Nature Medicine(2023)10.1038/s41591-023-02502-5

N/A

0.805DataRank · unranked

213 citations

Jordi Merino, Abrar Ahmad, Catherine Aiken, Jamie L. Benham, Dhanasekaran Bodhini +95 more

Precision subclassification of type 2 diabetes: a systematic review

Communications Medicine(2023)10.1038/s43856-023-00360-3

N/A

0.702DataRank · unranked

107 citations

Róbert Wágner, Bige Özkan, Martin Schön, Magdalena Sevilla-González, Katsiaryna Prystupa +87 more

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

Diabetes Care(2023)10.2337/dc22-2200

N/A

0.691DataRank · unranked

99 citations

Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland +21 more

Hydroxychloroquine in Stage 1 Type 1 Diabetes

Diabetes Care(2023)10.2337/dc23-1096

N/A

0.622DataRank · unranked

17 citations

Polly J. Bingley, Dorothy J. Becker, Jane H. Buckner, Linda A. DiMeglio, Stephen E. Gitelman +58 more

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00267-x

N/A

0.612DataRank · unranked

58 citations

Kimberly S. Collins, Anna Lam, Stephen R. Karpen, Brianna Greeno, Frank Walker +38 more

Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review

Communications Medicine(2023)10.1038/s43856-023-00359-w

N/A

0.561DataRank · unranked

41 citations

Eram Haider McInnes, Robert Massey, Anna R. Kahkoska, Scott J. Pilla, Sridharan Raghavan +89 more

The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk

Diabetes Care(2022)10.2337/dc22-0167

N/A

0.558DataRank · unranked

7 citations

David Cuthbertson, Stephen E. Gitelman, Jay S. Skyler, Andrea K. Steck, Henry Rodriguez +9 more

Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis

Communications Medicine(2023)10.1038/s43856-023-00393-8

N/A

0.520DataRank · unranked

31 citations

Camille E. Powe, William L. Lowe, Sara L. White, Denise Scholtens, Jiaxi Yang +95 more

The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa348

N/A

0.495DataRank · unranked

7 citations

Mario A. Cleves, Jay M. Sosenko, Ingrid Libman, David A. Baidal, Ashok Balasubramanyam +80 more

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Communications Medicine(2023)10.1038/s43856-023-00357-y

N/A

0.494DataRank · unranked

26 citations

Kurt Griffin, Richard A. Oram, Cate Speake, S. Alice Long, Suna Önengüt-Gümüşcü +89 more

Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review

Communications Medicine(2023)10.1038/s43856-023-00363-0

N/A

0.477DataRank · unranked

23 citations

Robert W. Morton, Vanessa Santhakumar, Mariam Nakabuye, Hugo Pomares‐Millan, Christoffer Clemmensen +92 more

Precision treatment of beta-cell monogenic diabetes: a systematic review

Communications Medicine(2024)10.1038/s43856-024-00556-1

N/A

0.477DataRank · unranked

23 citations

Kashyap A. Patel, Jarno L. T. Kettunen, Jonna M. E. Männistö, Julie Støy, Jacques Beltrand +94 more

Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review

Communications Medicine(2024)10.1038/s43856-023-00427-1

N/A

0.470DataRank · unranked

22 citations

Romy Gaillard, Alice E. Hughes, Kristen E. Boyle, Deirdre K. Tobias, ADA/EASD PMDI +92 more

Clinical trial data validate the C-peptide estimate model in type 1 diabetes

Diabetologia(2020)10.1007/s00125-020-05088-6

N/A

0.312DataRank · unranked

7 citations

Naiara G. Bediaga, Stephen E. Gitelman, Carmela Evans-Molina, Peter A. Gottlieb, Peter G. Colman +3 more

The Role of Imatinib in Pediatric Type 1 Diabetes

JCEM Case Reports(2024)10.1210/jcemcr/luae065

N/A

0.269DataRank · unranked

5 citations

Chester E. Chamberlain, Michael German, Mark S. Anderson, Angel Nip, Stephen E. Gitelman +1 more

Serum Metabolomics Reveals Potential Differences in Gut Microbiota–Associated Metabolites in Twins Discordant for Type 1 Diabetes

Diabetes(2025)10.2337/db25-0156

N/A

0DataRank · unranked

2 citations

Michael W. Christopher, Esabella R. Powers, Hali Broncucia, Andrea K. Steck, Stephen E. Gitelman +3 more

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Science Translational Medicine(2021)10.1126/scitranslmed.abc8980

N/A

0DataRank · unranked

361 citations

Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long +18 more

Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample

Diabetologia(2021)10.1007/s00125-021-05523-2

N/A

0DataRank · unranked

33 citations

Connie S.N. Li Wai Suen, Michael J. Haller, Stephen E. Gitelman, Carmella Evans‐Molina, Peter A. Gottlieb +9 more

Continuous Glucose Monitoring to Diagnose Hypoglycemia Due to Late Dumping Syndrome in Children After Gastric Surgeries

Journal of the Endocrine Society(2021)10.1210/jendso/bvaa197

N/A

0DataRank · unranked

13 citations

Fatema Abdulhussein, Alyssa Huang, Janet Y. Lee, Stephen E. Gitelman, Hannah Chesser

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review

Communications Medicine(2023)10.1038/s43856-023-00358-x

N/A

0DataRank · unranked

26 citations

Jennifer L. Sherr, Elizabeth G. Considine, Angela Chen, Sarah Peeling, Margo Hulsmans +93 more

β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes

Diabetes(2023)10.2337/db23-0196

N/A

0DataRank · unranked

4 citations

Carmella Evans‐Molina, Annamaria Guolo, Andrea Mari, Ele Ferrannini, Stephen E. Gitelman

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

Communications Medicine(2024)10.1038/s43856-024-00478-y

N/A

0DataRank · unranked

46 citations

María J. Redondo, Richard A. Oram, Cate Speake, S. Alice Long, Suna Önengüt-Gümüşcü +89 more

Time to reframe the disease staging system for type 1 diabetes

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00239-0

N/A

0DataRank · unranked

10 citations

Mark A. Atkinson, Jay M. Sosenko, Stephen E. Gitelman, Laura M. Jacobsen

Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes Care(2024)10.2337/dc24-0171

N/A

0DataRank · unranked

6 citations

David Cuthbertson, Brian N. Bundy, Mark A. Atkinson, Wayne D. Moore, Michael J. Haller +13 more

Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes

Diabetes Obesity and Metabolism(2025)10.1111/dom.16246

N/A

0DataRank · unranked

6 citations

Kimber M. Simmons, Stephen E. Gitelman, Terry Dex, Robert Hill, Mattias Wieloch +6 more

Exenatide extended release in patients with type 1 diabetes with and without residual insulin production

Diabetes Obesity and Metabolism(2020)10.1111/dom.14121

N/A

0DataRank · unranked

43 citations

Jesse Reynolds, James Dziura, David A. Baidal, Jason L. Gaglia, Stephen E. Gitelman +6 more